Anthera Pharmaceuticals, Inc. (ANTH)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2017 | 2016 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | 145 Thousand |
| Cost of Revenue | - | - | - | - | 281 Thousand | 46.25 Thousand |
| Gross Profit | - | - | - | - | -281 Thousand | 98.74 Thousand |
| Operating Expenses | - | - | - | - | 36.53 Million | 57.32 Million |
| Selling, General and Administrative Expenses | - | - | - | - | 7.93 Million | 11.07 Million |
| Research and Development Expenses | - | - | - | - | 28.59 Million | 46.25 Million |
| Other Expenses | - | - | - | - | -85 Thousand | - |
| Cost and Expenses | - | - | - | - | 36.53 Million | 57.32 Million |
| Operating Income | - | - | - | - | -36.43 Million | -57.17 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | - | - | - | - | -9.93 Million | -1.92 Million |
| Earnings before Tax | - | - | - | - | -26.87 Million | -55.52 Million |
| Net Income | - | - | - | - | -16.93 Million | -53.6 Million |
| Earnings Per Share Basic | - | - | - | - | -1.65 | -10.38 |
| Earnings Per Share Diluted | - | - | - | - | -1.65 | -10.38 |
| Weighted Average Shares Outstanding | - | - | - | - | 10.27 Million | 5.16 Million |
| Weighted Average Shares Outstanding (Diluted) | - | - | - | - | 10.27 Million | 5.16 Million |
| Gross Margin | - | - | - | - | - | 0.68 |
| EBIT Margin | - | - | - | - | - | -405.73 |
| Profit Margin | - | - | - | - | - | -369.68 |
| EBITDA | - | - | - | - | -26.59 Million | -56.91 Million |
| Earnings Before Tax Margin | - | - | - | - | - | -394.32 |
| Breakdown | 2022 FY | 2021 FY | 2020 FY | 2019 FY | 2018 Q1 | 2017 FY |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | 7468.00 | 281 Thousand |
| Gross Profit | - | - | - | - | -7468.00 | -281 Thousand |
| Operating Expenses | - | - | - | - | 10.97 Million | 36.53 Million |
| Selling, General and Administrative Expenses | - | - | - | - | 3.5 Million | - |
| Research and Development Expenses | - | - | - | - | 7.46 Million | - |
| Other Expenses | - | - | - | - | -43 Thousand | -85 Thousand |
| Cost and Expenses | - | - | - | - | 10.97 Million | 36.53 Million |
| Operating Income | - | - | - | - | -10.97 Million | -36.43 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | - | - | - | - | -3.29 Million | -9.93 Million |
| Earnings before Tax | - | - | - | - | -7.72 Million | -26.87 Million |
| Net Income | - | - | - | - | -4.43 Million | -16.93 Million |
| Earnings Per Share Basic | - | - | - | - | -0.20 | - |
| Earnings Per Share Diluted | - | - | - | - | -0.20 | - |
| Weighted Average Shares Outstanding | - | - | - | - | 22.16 Million | 10.27 Million |
| Weighted Average Shares Outstanding (Diluted) | - | - | - | - | 22.16 Million | 10.27 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | - | - | - | - | -14.1 Million | - |
| Earnings Before Tax Margin | - | - | - | - | - | - |
DLPX
VARIMAN
KAP
NSHRF
5102
688101